Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

16.99
Delayed Data
As of 4:00pm ET
 +0.22 / +1.31%
Today’s Change
15.92
Today|||52-Week Range
44.57
-60.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues193.3M190.5M186.5M177.5M
 
 
 
 
 
Cost of Goods Sold33.8M33.6M33.3M30.8M
 
 
 
 
 
Depreciation And Amortization6.8M6.6M6.7M9.2M
 
 
 
 
 
 
Operating ExpensesGross Income152.7M150.3M146.5M137.5M
 
 
 
 
 
General Expenses107.5M107.7M110.8M131.3M
 
 
 
 
 
Research And Development16.7M17.2M19.5M19.4M
 
 
 
 
 
Total Operating Expenses148.1M147.9M150.8M171.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income45.2M42.6M35.7M6.2M
 
 
 
 
 
Other Expenses-300.0K200.0K1.2M-2.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income45.0M43.1M37.3M4.0M
 
 
 
 
 
Income Taxes-14.7M-10.5M-13.9M-5.2M
 
 
 
 
 
Net Income30.3M32.6M23.4M-1.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS70.5M70.9M70.0M68.8M
 
 
 
 
 
Shares To Calculate EPS Diluted73.8M73.5M72.4M68.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.41$0.44$0.32-$0.02
 
 
 
 
 
EPS Diluted$0.41$0.44$0.32-$0.02